ELP2-GALNT1 Fusion FISH Probe
The ELP2-GALNT1 Fusion FISH Probe is used to confirm a fusion of the ELP2 and GALNT1 genes. The fusion of the ELP2 and GALNT1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ELP2-GALNT1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ELP2-GALNT1-20-AQAQ | 20 (40 μL) | 200 μL |
|
GALNT1 Gene Summary
This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. Transcript variants derived from this gene that utilize alternative polyA signals have been described in the literature. [provided by RefSeq, Jul 2008]
Gene Name: Polypeptide N-acetylgalactosaminyltransferase 1
Chromosome: CHR18: 33234532 -33291798
Locus: 18q12.2
ELP2 Gene Summary
The protein encoded by this gene is a core subunit of the elongator complex, a histone acetyltransferase complex that associates with RNA polymerase II. In addition to histone acetylation, the encoded protein effects transcriptional elongation and may help remodel chromatin. [provided by RefSeq, May 2016]
Gene Name: Elongator Acetyltransferase Complex Subunit 2
Chromosome: CHR18: 33709836 -33754688
Locus: 18q12.2
Gene Diseases
The ELP2 GALNT1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|